Vertex Pharmaceuticals (VRTX) valuation history
Above its usual range
As of
VRTX's P/S of 10.6x is higher than 70% of its available weekly readings from the last five years.
Share P/S history
Chart by stockresearch.app. Reuse with credit under CC BY 4.0.
P/S at year-end
Last weekly reading of each completed year. Rank runs from lowest (0%) to highest (100%) within the five years available on that date.
| Reading date | P/S | 5-year rank |
|---|---|---|
| 9.9× | 61% | |
| 10.0× | 57% | |
| 11.0× | 64% | |
| 8.6× | 17% | |
| 8.0× | 9% | |
| 10.4× | 4% | |
| 15.7× | 32% | |
| 15.9× | 26% | |
| 16.3× | 48% | |
| 10.9× | 27% |
Loading related research…
About this history
- What is VRTX's current P/S?
- VRTX's P/S of 10.6x is higher than 70% of its available weekly readings from the last five years.
- What is VRTX's five-year median P/S?
- The median, or middle weekly reading, is 9.8× over the last five years. Available history contains 818 weekly observations from Feb 21, 2011 to Oct 19, 2026.
- Does a low historical rank mean a stock is a buy?
- No. The rank describes a stock’s own history. Changes in growth, financial risk and the business can change the multiple investors pay. P/E uses earnings and P/S uses revenue from the previous twelve months.